PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 8 filers reported holding PASITHEA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,799 | -39.1% | 289,868 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,234 | -28.3% | 289,968 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $8,699 | -8.9% | 289,968 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $9,554 | -76.1% | 289,968 | -6.7% | 0.00% | -85.7% |
| Q3 2022 | $40,000 | +100.0% | 310,883 | -0.1% | 0.01% | +75.0% |
| Q2 2022 | $20,000 | -80.4% | 311,183 | -48.1% | 0.00% | – |
| Q1 2022 | $102,000 | +25.9% | 599,816 | +174.0% | 0.00% | -100.0% |
| Q4 2021 | $81,000 | – | 218,920 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kepos Capital LP | 400,000 | $320,000 | 0.02% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $800,000 | 0.01% |
| UBS Group AG | 45 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |